Tech Company Financing Transactions

Sirnaomics Funding Round

Value Measured Investment and private investors invested in a $10 million funding round for Sirnaomics. This VC investment round was recorded on 4/30/2016.

Transaction Overview

Company Name
Announced On
4/30/2016
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors

Value Measured Investment (Lead Investor)

Proceeds Purpose
The proceeds will be used to fund clinical development of its first-in-class anti-fibrosis programs and the company expects to enter Phase I clinical trial with its lead product candidate, STP705, early second half of 2016.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
401 Professional Dr. 280
Gaithersburg, MD 20879
USA
Email Address
Overview
Sirnaomics, Inc. is a biopharmaceutical company discovering and developing novel targeted therapeutics for critical human diseases by using RNA interference (RNAi) technology.
Profile
Sirnaomics LinkedIn Company Profile
Social Media
Sirnaomics Company Twitter Account
Company News
Sirnaomics News
Facebook
Sirnaomics on Facebook
YouTube
Sirnaomics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Patrick Lu
  Patrick Lu LinkedIn Profile  Patrick Lu Twitter Account  Patrick Lu News  Patrick Lu on Facebook
Chief Medical Officer
Michael Molyneaux
  Michael Molyneaux LinkedIn Profile  Michael Molyneaux Twitter Account  Michael Molyneaux News  Michael Molyneaux on Facebook
Chief Operating Officer
George Ji
  George Ji LinkedIn Profile  George Ji Twitter Account  George Ji News  George Ji on Facebook
Chief Scientific Officer
David Evans
  David Evans LinkedIn Profile  David Evans Twitter Account  David Evans News  David Evans on Facebook
Chief Technical Officer
Dmitry Samarsky
  Dmitry Samarsky LinkedIn Profile  Dmitry Samarsky Twitter Account  Dmitry Samarsky News  Dmitry Samarsky on Facebook
VP - Finance
Nigel Yip
  Nigel Yip LinkedIn Profile  Nigel Yip Twitter Account  Nigel Yip News  Nigel Yip on Facebook
VP - Human Resources
John Buergenthal
  John Buergenthal LinkedIn Profile  John Buergenthal Twitter Account  John Buergenthal News  John Buergenthal on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/30/2016: FLX Bio venture capital transaction
Next: 4/30/2016: SparkFund venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary